Ad
related to: schizoaffective disorder fda approved drugs for rls treatment 10 25 mg high blood pressure
Search results
Results from the WOW.Com Content Network
It is indicated in the treatment of schizophrenia and schizoaffective disorder. [14] It is marketed by Janssen Pharmaceuticals. [4] Paliperidone was approved by the US Food and Drug Administration (FDA) for the treatment of schizophrenia in December 2006, [4] and in the European Union in June 2007. [8]
This is a list of psychiatric medications used by psychiatrists and other physicians to treat mental illness or distress. The list is ordered alphabetically according to the condition or conditions, then by the generic name of each medication. The list is not exhaustive and not all drugs are used regularly in all countries.
The primary treatment of schizoaffective disorder is medication, with improved outcomes using combined long-term psychological and social supports. [23] Hospitalization may occur for severe episodes either voluntarily or (if mental health legislation allows it) involuntarily.
Stelazine (trifluoperazine) – an antipsychotic used in the treatment of psychotic disorders, anxiety, and nausea caused by chemotherapy [2] Strattera (atomoxetine) – a non-stimulant medication used to treat ADHD; Suboxone (buprenorphine/naloxone) - a partial opioid agonist used in the treatment of opioid use disorder
Clozapine, sold under the brand name Clozaril among others, is a psychiatric medication and was the first atypical antipsychotic to be discovered. [6] It is primarily used to treat people with schizophrenia and schizoaffective disorder who have had an inadequate response to two other antipsychotics, or who have been unable to tolerate other drugs due to extrapyramidal side effects.
The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S.
The disorder causes low calcium levels and high phosphorus levels in the blood, in which patients suffer from muscle cramps, seizures and long-term symptoms such as high risk of kidney disease and ...
The approval is based on a late-stage study in which PiaSky showed a 79.3% control in the destruction of red blood cells versus 79% for the standard-of-care eculizumab from week 5 to week 25.
Ad
related to: schizoaffective disorder fda approved drugs for rls treatment 10 25 mg high blood pressure